Targeted vs Standard Contact Precautions and Transmission of Methicillin-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococci in Critically Ill Adults
CHEST Critical Care · 2026-09 · 4 (3) · 100282
DOI: 10.1016/j.chstcc.2026.100282 ↗Kurz gefasst
Fachartikel in der Zeitschrift CHEST Critical Care, 2026-09. Verfasst von Luis E Huerta und 12 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, Keck School of Medicine of USC, Los Angeles, CA. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCATS NIH HHS, NHLBI NIH HHS, NIAID NIH HHS.
Abstract (Originalsprache)
BACKGROUND: Contact precautions are used commonly to prevent nosocomial transmission of methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococci (VRE). Whether targeted contact precautions are as effective at preventing nosocomial infection as contact precautions for all patients with MRSA and VRE is uncertain. RESEARCH QUESTION: Compared with standard contact precautions, are targeted contact precautions able to reduce the number of days patients spend in contact precautions and are they as effective at preventing hospital-acquired infection with MRSA and VRE? STUDY DESIGN AND METHODS: A pragmatic, single-center, single-cluster, crossover pilot and feasibility trial in which all adults admitted to a single medical ICU alternated every 2 months between targeted and standard contact precautions for MRSA and VRE for a total of 8 months. In targeted periods, patients received contact precautions only for highly transmissible MRSA or VRE infections, including open wounds, uncontrolled diarrhea, or pneumonia. In standard periods, patients received contact precautions for any MRSA or VRE infection or colonization. The primary pilot outcome was hospital-acquired infection with MRSA or VRE. The primary feasibility outcome was the number of patients per day removed from contact precautions in the targeted group. RESULTS: The trial enrolled 2,230 adults. During targeted months, 0.56 additional patients/d remained without contact precautions. Thirteen hospital-acquired infections with MRSA or VRE occurred during targeted months compared with 13 infections during standard months (P = .95). MRSA acquisition was higher in the targeted group (6.5% vs 3%; P = .03). INTERPRETATION: Despite a slight reduction in patient-days spent with contact precautions during the targeted contact precautions periods, no statistically significant difference was found in hospital-acquired MRSA or VRE infections when comparing targeted with standard contact precautions in this pilot trial. Larger, multicenter trials should examine the benefits and risks of these interventions. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov; No.: NCT03268122; URL: www.clinicaltrials.gov.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, Keck School of Medicine of USC, Los Angeles, CA.
- Division of Infectious Diseases, Vanderbilt University Medical Center, Nashville, TN.
- Division of Allergy, Pulmonary, and Critical Care Medicine, Vanderbilt University Medical Center, Nashville, TN.
- Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of Maryland School of Medicine, Baltimore MD.
- Department of Medicine, the Department of Anesthesiology, Vanderbilt University Medical Center, Nashville, TN.
- Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN.
Förderung
- NCATS NIH HHS
- NHLBI NIH HHS
- NIAID NIH HHS
- National Center for Advancing Translational Sciences
- National Heart Lung and Blood Institute Division of Intramural Research
- National Institutes of Health
- National Institute of Allergy and Infectious Diseases
- National Heart, Lung, and Blood Institute
Zitieren
APA
Huerta, L. E., Nelson, G. E., Semler, M. W., Talbot, T. R., Noto, M. J., Wanderer, J. P., Freundlich, R. E., Creech, C. B., Thomsen, I. P., Soper, N., Lindsell, C. J., Nwosu, S., & Rice, T. W. (2026). Targeted vs Standard Contact Precautions and Transmission of Methicillin-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococci in Critically Ill Adults. CHEST Critical Care, 4(3), 100282. https://doi.org/10.1016/j.chstcc.2026.100282
Vancouver
Huerta LE, Nelson GE, Semler MW, Talbot TR, Noto MJ, Wanderer JP, et al. Targeted vs Standard Contact Precautions and Transmission of Methicillin-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococci in Critically Ill Adults. CHEST Critical Care. 2026;4(3):100282. doi:10.1016/j.chstcc.2026.100282
BibTeX
@article{Huerta2026,
author = {Huerta, Luis E and Nelson, George E and Semler, Matthew W and Talbot, Thomas R and Noto, Michael J and Wanderer, Jonathan P and Freundlich, Robert E and Creech, C Buddy and Thomsen, Isaac P and Soper, Nicole and Lindsell, Christopher J and Nwosu, Samuel and Rice, Todd W},
title = {Targeted vs Standard Contact Precautions and Transmission of Methicillin-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococci in Critically Ill Adults},
journal = {CHEST Critical Care},
year = {2026},
volume = {4},
number = {3},
pages = {100282},
doi = {10.1016/j.chstcc.2026.100282}
}
EUVIMED